CureVac N.V. is a German biopharmaceutical company. It develops therapies based on messenger RNA (mRNA). Headquartered in Tübingen, Germany, the company...

The CureVac COVID-19 vaccine (abbreviated CVnCoV) was a COVID-19 vaccine candidate developed by CureVac N.V. and the Coalition for Epidemic Preparedness...

including Deutsche Post, Deutsche Telekom, Commerzbank, Lufthansa, and CureVac. In 2013, KfW agreed to help establish a Portuguese financial institution...

additional companies such as Viacyte (part of Vertex), Nkarta, Capsida, Curevac, and others. CRISPR Therapeutics has drugs approved and in development...

concerning the use of RNA and is a founder of the German biotechnology company CureVac. He created the initial technology used in RNA vaccines and has reportedly...

CSL; 1904– ) CSPC Pharmaceutical Group (1992- ) CSPC Zhongrun (1989– ) CureVac (2000– ) CytRx (1985– ) Daiichi Sankyo (2005– ) Debiopharm (1979– ) Dechra...

Moderna, AstraZeneca, and Janssen. Iceland has also signed a contract with CureVac. Iceland signed a contract on December 9, 2020, with Pfizer, and a contract...

(€955 million). In July 2020, GSK acquired a 10% stake in German biotech company CureVac. In March 2018, GSK announced that it has reached an agreement with Novartis...

patent on Moderna's mRNA vaccine technology, are ongoing. DNA vaccine CureVac "Moderna, Inc., 2023, Form 10-K Annual Report". U.S. Securities and Exchange...

Zeiss AG Health care Medical equipment Oberkochen 1846 Optical systems CureVac Health care Vaccine Tübingen 2000 Biotechnology Celesio Health care Pharmaceuticals...